MRVI — Maravai Lifesciences Holdings Share News
0.000.00%
- $1.84bn
- $2.09bn
- $185.74m
Brief: Maravai Lifesciences Appoints R. Andrew Eckert As Chairman Of The Board Of Directors
U.S. STOCKS ON THE MOVE-Fortinet, Molson Coors, Corpay
Maravai LifeSciences falls after annual revenue forecast cut
Maravai LifeSciences Holdings Inc reports results for the quarter ended in September 30 - Earnings Summary
Brief: Maravai LifeSciences Q3 Revenue USD 65.2 Million Vs. IBES Estimate USD 67.6 Million
Brief: Maravai Lifesciences Holdings-On Sept 10, Amended Existing Credit Agreement To Extend Maturity Date Of Revolving Credit Facility By Five Years
U.S. STOCKS ON THE MOVE-Li Auto, NVIDIA, CrowdStrike
U.S. STOCKS ON THE MOVE-Berkshire Hathaway, Super Micro Computer, Elf Beauty
Maravai climbs on collaboration to launch DNA concentration testing kit
U.S. STOCKS ON THE MOVE-Chewy, Abercrombie & Fitch, Kohl's
Maravai climbs on collaboration to launch DNA concentration testing kit
Repligen in bid for reagent vendor Maravai, sources say
Repligen falls after report company bids to acquire Maravai LifeSciences
Repligen in bid for reagent vendor Maravai, sources say
Maravai LifeSciences Holdings Inc reports results for the quarter ended in January - Earnings Summary
Brief: Maravai LifeSciences Q2 Revenue USD 58.483 Million Vs. IBES Estimate USD 71.6 Million
Maravai LifeSciences Holdings Inc expected to post breakeven results a share - Earnings Preview
Brief: Maravai LifeSciences Appoints Trey Martin To Board Of Directors
Brief: Maravai LifeSciences Q1 Revenue USD 64.179 Million Vs. IBES Estimate USD 60.5 Million